Secretory PLA2-IIA: A New Inflammatory Factor for Alzheimer's Disease
Author Information
Author(s): Moses Guna SD, Jensen Michael D, Lue Lih-Fen, Walker Douglas G, Sun Albert Y, Simonyi Agnes, Sun Grace Y
Primary Institution: Sun Health Research Institute
Hypothesis
Is secretory phospholipase A2-IIA (sPLA2-IIA) involved in the inflammatory processes of Alzheimer's disease?
Conclusion
The study found that sPLA2-IIA is up-regulated in Alzheimer's disease brains, suggesting its role in the disease's inflammatory processes.
Supporting Evidence
- sPLA2-IIA mRNA is significantly up-regulated in Alzheimer's disease brains compared to non-demented brains.
- Immunohistochemistry showed a higher percentage of sPLA2-IIA-positive astrocytes in Alzheimer's disease brains.
- Pro-inflammatory cytokines and amyloid beta were shown to induce sPLA2-IIA mRNA expression in cultured human astrocytes.
Takeaway
Researchers found a protein called sPLA2-IIA that is more active in the brains of people with Alzheimer's disease, which might help explain why the disease causes inflammation.
Methodology
The study used real-time PCR and immunohistochemistry to analyze sPLA2-IIA expression in human brain tissues from Alzheimer's and non-demented subjects.
Potential Biases
Potential bias in sample selection and classification of Alzheimer's disease cases.
Limitations
The study is limited by the small sample size and the inability to study sPLA2-IIA in transgenic mouse models of Alzheimer's disease.
Participant Demographics
The study included 16 non-demented and 16 Alzheimer's disease subjects, with a mean age of 86.25 years for AD and 84.44 years for ND.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website